Drugs with this side effect
- 17-hydroxyprogesterone: postmarketing
- 5-ASA: postmarketing, 1% - 28%
- 5-aza-2'-deoxycytidine: 46.5%
- 5-azacytidine: very common, 1.96% - 35.9%
- 5-fluorocytosine
- ALX 111
- AMD3100: common, 0% - 27%
- Abarelix: 9.88%
- Azarga
- CAS 76095-16-4: 1.8% - 3%
- CAS 76420-72-9
- CGP 19835A: very common, 53%
- Cancidas: 0% - 6.7%
- Carfilzomib: 0.38% - 55.5%
- Colimycin M
- Depreotide
- EDTA
- Enfuvirtide: 16.1% - 17.4%
- FAMP: 10% - 38%
- FK463: 0%
- FTY720
- Fe(III: 6%
- Forteo: common
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: 9%
- Goserelin: 2% - 5%
- Histrelin
- ICI 182,780: 6.42% - 7.48%
- Implanon: postmarketing
- Insulin: 2%
- K779: postmarketing, 8% - 96%
- LY146032: postmarketing, uncommon
- Leuprorelin
- LiOH
- Lisinopril: postmarketing, uncommon, 2.7% - 7.1%
- MDV3100
- MK-462
- Mersyndol
- Metrodin: 2.26%
- NSC 352122
- NovoLog
- NuvaRing
- Octreotide: 5% - 9.65%
- Oestrogen
- Optison: postmarketing, uncommon
- PCI-32765: 2% - 30%
- Paroven
- Photofrin: 0% - 5.94%
- Photofrin II: common
- Promacta
- Romidepsin: 7% - 77.1%
- SOM230: 14.6% - 23.8%
- SU5416
- Sativex
- Saxagliptin
- Signifor: 14.6% - 23.8%
- SonoVue
- Stalevo 50
- Supremon
- Symlin
- TMC435: 25%
- Triptorelin: 2.1% - 2.3%
- UDCA: 4.5% - 7.8%
- VACV
- Vancocine
- Vitrum: 0.102%
- Zyprexa Relprevv: common
- abacavir: common, 0.971% - 33.7%
- abacavir-lamivudine: common
- abiraterone: 1.7% - 2.2%
- acebutolol: 4% - 17%
- acetaminophen: common, 1.59%
- acetazolamide
- acetohydroxamic acid
- acitretin: postmarketing, 1-10%
- actinomycin D
- acyclovir: common
- afatinib: 0% - 19%
- agomelatine
- alfentanil: 2%
- alfuzosin: 1.4% - 2.75%
- aliskiren
- almotriptan: infrequent
- alosetron: infrequent
- alpha-methyl-p-tyrosine
- alprazolam: 1.7% - 49%
- amantadine: common
- ambrisentan: postmarketing, 4.48% - 5.38%
- amiloride
- amiodarone
- amisulpride: 1%
- amitriptyline
- amlodipine: 4.5%
- amlodipine besylate: 4.5%
- amoxapine
- amphetamine
- amprenavir: very common, 1% - 2%
- amsacrine
- anagrelide
- anastrozole: 0.3% - 19%
- anthracycline: 6% - 44%
- apomorphine
- apraclonidine: postmarketing
- aprepitant: 0.9% - 21.9%
- aripiprazole: common, 2% - 17%
- arsenic
- arsenic trioxide
- asenapine: 2.75% - 4.65%
- atazanavir: common
- atenolol: postmarketing, 0.6% - 26%
- atomoxetine: common, 4% - 10%
- atorvastatin: postmarketing
- atropine: rare
- avanafil
- axitinib: 5% - 39%
- azelastine: 0% - 2.3%
- azilsartan
- azilsartan medoxomil
- azithromycin: postmarketing, 2.1% - 3.9%
- baclofen: common, 2-4%
- balsalazide: 2% - 6.06%
- belinostat: 5% - 37%
- benazepril: 2.4%
- benazeprilat: 2.4%
- bendamustine: 0% - 57%
- benzathine penicillin
- betahistine: rare
- betaxolol: postmarketing, 2.9% - 18.5%
- bexarotene
- bicalutamide: 15%
- bicarbonate
- bisoprolol: postmarketing, common, 6.6% - 8.2%
- boceprevir: very common, 50% - 59%
- bortezomib: 0% - 41%
- bosentan
- bosutinib: 24%
- brimonidine: very common, 1% - 15.2%
- brinzolamide: postmarketing
- bromazepam: postmarketing
- bromcresol green
- bromocriptine: postmarketing, uncommon, 1% - 7%
- budesonide: 0% - 8.21%
- bumetanide
- buprenorphine: 5%
- bupropion: 5%
- buspirone: 4%
- busulfan
- cabazitaxel: 3% - 5%
- cabergoline: postmarketing, 4.52% - 7-11%
- cabozantinib: 3% - 41%
- canagliflozin
- candesartan
- candesartan cilexetil: 1% - 1.5%
- capecitabine: 1% - 46%
- captopril
- carbamazepine: very common
- carbidopa
- carbinoxamine
- carboplatin
- carvedilol: 0.7% - 24%
- cefazolin
- cefpodoxime
- ceftobiprole
- celecoxib
- celiprolol
- cephalexin
- cephem
- cetirizine: 1.19% - 7%
- cevimeline: 3.3%
- chlorambucil
- chlorpheniramine
- ciclesonide
- cilazapril: postmarketing, 2.1% - 2.6%
- cimetidine: common, 1.7%
- cinacalcet: 7% - 20.7%
- ciprofloxacin
- citalopram: 0.8% - 16.7%
- cladribine: very common, 11% - 45%
- clarithromycin
- clemastine
- clindamycin
- clobazam: 3% - 5%
- clofarabine: very common, 14%
- clofazimine
- clomiphene citrate
- clomipramine: very common, 35% - 39%
- clonazepam: 7% - 8%
- clonidine: 4% - 16%
- clopidogrel
- clorazepate
- clozapine: 2%
- cobicistat: common
- codeine
- colchicine: 1.35% - 3.85%
- colesevelam: 3.88%
- colestipol
- colestyramine
- conjugated estrogens
- cortisol
- crizotinib: 26% - 27%
- cyclobenzaprine: 3% - 6%
- cyclophosphamide: postmarketing
- cyproheptadine
- cyproterone
- cyproterone acetate: very rare, common, very common
- cysteamine
- cytarabine: 6% - 46.4%
- d-telaprevir: 50%
- dabigatran etexilate
- dabrafenib: very common, 0% - 57%
- dacarbazine
- danazol
- dantrolene
- darunavir: 2.42% - 3.05%
- dasatinib: very common, 0% - 26%
- deferasirox: uncommon
- deferiprone
- degarelix: 3% - 6%
- delavirdine
- delta 9-THC: postmarketing
- demethyl
- deprenyl
- desflurane: postmarketing
- desipramine
- desloratadine: 1.2% - 2.1%
- desmopressin
- desvenlafaxine: 7% - 11%
- dexamethasone
- dexamethasone sodium phosphate
- dexrazoxane: 48% - 61%
- dextromethorphan: common
- diazepam
- diclofenac
- dicyclomine: postmarketing
- diflunisal
- dihydroergotamine: 1%
- diltiazem: 4.8%
- diphenhydramine
- dipyridamole: 1.2%
- disopyramide
- disulfiram
- docetaxel: 2.7% - 81.3%
- dolasetron: 2.55% - 12.2%
- dolutegravir
- donepezil: 1% - 8%
- dorzolamide
- dothiepin
- doxazosin: postmarketing, 8% - 14.8%
- doxepin: infrequent, 1.5% - 3.03%
- doxorubicin: 0% - 46%
- dronedarone
- duloxetine: 2% - 16%
- ecallantide: 12%
- efavirenz: common, 0% - 10%
- eletriptan
- eliglustat: 1.89% - 14.2%
- eltrombopag: 4% - 28%
- elvitegravir: common
- emtricitabine: 8%
- entacapone: common, 6% - 6.1%
- entecavir: common, 1% - 6%
- eplerenone: 2%
- eprosartan: 2%
- eribulin: 10% - 54%
- erlotinib: 4% - 73%
- ertapenem
- eslicarbazepine
- eslicarbazepine acetate
- esmolol: 1%
- esomeprazole magnesium
- estradiol: postmarketing
- estradiol valerate
- ethacrynic acid
- ethosuximide
- ethotoin
- etodolac
- etoposide
- etoposide phosphate
- etoricoxib
- etravirine: 3.3%
- everolimus: common, very common, 0% - 45%
- exemestane: very common, 7.5% - 29%
- exenatide: 0% - 6.1%
- ezetimibe: 1.4% - 2.8%
- famciclovir: 0.6% - 4.8%
- famotidine
- febuxostat
- felbamate: 4% - 16.8%
- felodipine
- fenofibrate: 2.04% - 3.27%
- fenofibric acid: 2.04% - 3.27%
- fenoprofen
- fentanyl: common, 0% - 20.5%
- ferumoxytol: postmarketing
- fesoterodine
- fexofenadine: 0.9% - 2.8%
- flecainide: 3% - 7.7%
- florbetapir: 0.5%
- fluconazole: postmarketing, uncommon
- fludarabine: 10% - 38%
- flumazenil
- flunisolide
- flunitrazepam: common
- fluoxetine: frequent, very common
- flutamide
- fluticasone
- fluvastatin: 0.2% - 2.7%
- fluvoxamine: postmarketing
- fondaparinux: rare
- formoterol
- fosamprenavir: common
- fosaprepitant
- fosaprepitant dimeglumine: 0.9% - 1.4%
- foscarnet
- fosinopril
- fosinoprilat
- frovatriptan
- furosemide
- gabapentin: 0.6% - 11%
- gadobenate dimeglumine
- gadodiamide
- gadofosveset
- gadolinium: 0.2%
- gadopentetate
- gadoversetamide
- galantamine: 4% - 5%
- ganciclovir
- gefitinib
- gemcitabine: 0% - 32%
- gemfibrozil: 0.9% - 3.8%
- gemifloxacin
- gliclazide
- glutamine: 0% - 13.3%
- glycerol phenylbutyrate: 2.22% - 6.82%
- glycopyrrolate: uncommon
- gonadorelin: 0% - 3.29%
- griseofulvin
- guanfacine: postmarketing, 2% - 14%
- halofantrine
- hepatitis B vaccines: very common
- hexamethylmelamine
- histamine
- hydrocodone: 0.662% - 4.12%
- hydromorphone: 1.49% - 11%
- hydroxybutyrate
- hydroxychloroquine
- hydroxyurea
- ibandronate: 1% - 3%
- ibuprofen
- icodextrin
- ifosfamide: 1%
- iloperidone: 4% - 6%
- imatinib: very common, 0% - 74.9%
- imipramine: common
- imiquimod: common, 0% - 4.38%
- indapamide
- indinavir: 2.1% - 24.3%
- indomethacin
- insulin detemir: 0.9% - 1.5%
- iodide
- iodixanol
- iopamidol
- ipratropium bromide
- irbesartan: common
- irbesartan-hydrochlorothiazide
- irinotecan
- iron sucrose
- isomannide
- isoniazid
- isosorbide-5-mononitrate
- isradipine: 3.9% - 6.3%
- itraconazole: postmarketing, 0% - 3%
- ivabradine
- ivermectin: 0.9%
- ixabepilone: 4% - 56%
- ketoconazole
- ketoprofen
- ketorolac tromethamine
- labetalol: 5% - 12%
- lacosamide: 0% - 18%
- lamivudine: common, 1% - 26%
- lamotrigine: 6% - 8%
- lanreotide
- lansoprazole
- lapatinib: very common, 0% - 21%
- lasofoxifene: uncommon
- leflunomide
- lenalidomide: postmarketing, very common, 4.7% - 43.9%
- lercanidipine: common
- letrozole: common, 0.151% - 11-30%
- leucovorin: 2% - 13%
- leuprorelin acetate
- levetiracetam: very common, 10% - 15%
- levocabastine
- levodopa/carbidopa
- levonorgestrel: postmarketing, 8% - 36.8%
- linaclotide
- linezolid
- liraglutide: postmarketing
- lisdexamfetamine dimesylate: postmarketing
- lisuride
- lithium
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- lomefloxacin
- lomitapide
- loperamide: postmarketing
- loratadine: 3.36% - 9.02%
- lorazepam
- lorcaserin: 7.17% - 7.42%
- lormetazepam
- losartan: 3.8% - 14%
- lovastatin
- loxapine: common
- lubiprostone: 2%
- lurasidone: 3% - 4%
- malvidin: 1% - 13%
- mannitol
- maprotiline: 4%
- maraviroc
- mecamylamine
- meclofenamate: postmarketing
- medroxyprogesterone: 4.2%
- medroxyprogesterone acetate
- mefloquine: postmarketing
- melatonin
- meloxicam: 0% - 2.2%
- melphalan
- memantine: 2% - 2.69%
- mephenytoin
- mesna: 33%
- metaproterenol: 1.4% - 7%
- metformin
- methazolamide
- methotrexate
- methyl aminolevulinate
- methylphenidate: 4.7%
- methylprednisolone
- methysergide
- metoclopramide: postmarketing
- metolazone: 4.4%
- metoprolol: common, very common
- metronidazole: 2%
- mexiletine: 1.4% - 5.7%
- mianserin
- miconazole: 2.1% - 2.8%
- midazolam
- mifepristone: 48%
- miglustat: common, 2.5%
- milnacipran
- minocycline: 9.2%
- mipomersen: 15%
- mirabegron: 1.2% - 1.4%
- mirtazapine: postmarketing
- misoprostol: postmarketing
- mitomycin C
- mitoxantrone
- moclobemide
- modafinil: postmarketing, 2%
- moexiprilat: 2.37%
- mometasone
- mometasone furoate
- monamine
- montelukast: postmarketing, 1.8%
- morphine: postmarketing
- moxifloxacin
- mycophenolic acid
- nabilone
- nabumetone: 2%
- nadolol: 2%
- nalmefene
- naltrexone: postmarketing, 4%
- naproxen
- naratriptan: 2% - 11%
- nateglinide: 0.8%
- nebivolol: 2% - 5%
- nedocromil sodium
- nelarabine: 2% - 50%
- nevirapine: postmarketing, common, 0.2% - 5%
- nicotine
- nifedipine: 1.2% - 6.2%
- nilotinib: very common, 0% - 17%
- nitrazepam
- nitrite
- norethisterone
- norfloxacin: postmarketing
- nortriptyline
- ofatumumab: 0% - 15%
- ofloxacin
- olanzapine: common, 1.5% - 14%
- olmesartan: postmarketing, common, 0% - 1.41%
- olmesartan medoxomil
- olopatadine: 0.675% - 0.852%
- olsalazine: 1.8%
- omeprazole: postmarketing, 1%
- ondansetron: 2.29% - 13.2%
- orlistat: 3.1% - 7.2%
- oseltamivir: postmarketing
- oxaliplatin: very common, 0% - 70.3%
- oxcarbazepine: very common, 1.1% - 21%
- oxprenolol
- oxybutynin: 2.06% - 3.1%
- oxycodone
- oxymorphone: 3.9% - 4%
- paclitaxel: 4% - 8%
- paliperidone: common, 0% - 4%
- palonosetron: 0.474% - 2.06%
- pamidronate: very common, 0% - 40.3%
- pantoprazole: postmarketing, 1.1%
- paricalcitol: 2% - 3.3%
- paroxetine: 4.88%
- pazopanib: 0% - 65%
- pegaptanib
- pemetrexed: 0% - 87%
- penbutolol: 0% - 4.4%
- penciclovir: 0.6% - 4.8%
- penicillin
- pentamidine: 65.7%
- pentostatin: 29% - 55%
- perampanel: 8% - 12%
- perindopril erbumine
- phenelzine
- phenoxybenzamine
- phentermine
- phenylbutyric acid
- phenytoin
- phosphate
- pindolol: 4% - 8%
- pioglitazone: 2.5%
- piperacillin
- pirbuterol: 0% - 0.7%
- pirfenidone
- pitavastatin: postmarketing
- pixantrone
- pizotifen
- pomalidomide: 4.7% - 62.5%
- ponatinib: 3% - 39%
- posaconazole: 3.23% - 13%
- potassium phosphate
- pralatrexate
- pramipexole: postmarketing, common, 3% - 9%
- prasugrel: 3.7% - 4.8%
- pravastatin: 1.9% - 8.4%
- praziquantel
- prazosin: 7%
- prednisolone phosphate
- prednisone
- pregabalin: 5.3% - 11%
- primidone
- procarbazine
- progesterone: 1.73% - 9%
- promethazine
- propafenone: postmarketing, 1% - 12.5%
- propofol
- propranolol: postmarketing, 4.49% - 7.06%
- prostacyclin
- protriptyline
- prucalopride: common
- pyrantel
- quazepam: 2%
- quetiapine: 2.6% - 14.3%
- quinapril
- quinaprilat
- quinidine: 7% - 17%
- raltegravir
- ramelteon: 0.3% - 4%
- ramipril
- ramiprilat
- ranolazine
- regorafenib
- retigabine: 3% - 16%
- retinoic acid: postmarketing
- ribavirin: very common, 17% - 70%
- rifampicin
- rifapentine
- rifaximin: 12.1%
- rilpivirine: 2%
- riluzole
- rimantadine: 0.9% - 1%
- rimonabant
- risedronate: 1.5% - 6.3%
- risperidone: frequent, 0% - 42%
- ritonavir
- rivaroxaban: 1%
- rivastigmine: common, 0% - 9%
- rizatriptan: 4% - 7%
- rofecoxib: 1% - 2.6%
- roflumilast
- ropinirole: 7% - 11%
- rosiglitazone: 1.9% - 9%
- rotigotine: 8%
- rufinamide: 2% - 16%
- ruxolitinib
- salbutamol: 1%
- salmeterol
- salmon calcitonin acetate: postmarketing, common
- saquinavir: common
- scopolamine
- sertraline: postmarketing, very common, 2% - 16%
- sevelamer: 3%
- sevelamer hydrochloride: 3.1%
- sildenafil: postmarketing, uncommon
- simvastatin
- sitagliptin
- sitaxsentan: common, 2.68%
- sodium
- sodium acetate
- sodium cromoglycate
- sodium ferric gluconate: 6%
- sofosbuvir: very common, 24% - 59%
- solifenacin: 1% - 2.1%
- sorafenib: postmarketing, 1% - 46%
- sotalol: 2% - 20%
- stavudine: common
- stiripentol
- sulfamethoxazole
- sulindac
- sumatriptan: common, 0.4% - 9.5%
- sunitinib: 1% - 10%
- tacrolimus: 1.79% - 15.9%
- tadalafil: 6%
- tamoxifen: 1% - 18.6%
- tamsulosin
- tapentadol: 3% - 9%
- technetium-99m
- tegaserod: 1%
- telavancin: common
- telithromycin
- telmisartan: postmarketing, 3.2%
- temazepam: 4.7% - 4.8%
- temozolomide: very common, 2% - 61.2%
- temsirolimus
- tenofovir: 8%
- tenofovir disoproxil fumarate: 7.44% - 8.45%
- tenoxicam: uncommon
- terazosin
- terbinafine: very rare, postmarketing, common, 0.3% - 3%
- testosterone: postmarketing, uncommon, 1.96%
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine: 22%
- tetraen
- thalidomide: 1.96% - 79.4%
- thiabendazole
- thiotepa: 1-10%
- thiothixene
- thymidine: 1% - 12.5%
- thyroxine
- tiagabine
- tiaprofenic acid
- ticagrelor: 3.2%
- timolol: 1% - 5%
- tinidazole: 1.1% - 2.1%
- tiopronin
- tipranavir: common, 5.6%
- tizanidine: postmarketing, 41%
- tofacitinib
- tolazamide
- tolcapone: 7%
- tolterodine: 1.2%
- topiramate: postmarketing, rare, 1% - 30.7%
- topotecan: very common, 0% - 29%
- toremifene
- trabectedin
- tramadol: common, 1.7% - 4.2%
- tramazoline
- trametinib: 2% - 57%
- trandolapril
- trandolaprilat
- tranexamic acid: 5.17%
- travoprost
- trazodone: 5.7% - 14.9%
- treprostinil
- triamcinolone: postmarketing
- triamcinolone acetonide: postmarketing
- triamterene
- triazolam
- trifluoperazine
- trimethadione
- trimetrexate: 0% - 1.83%
- trimipramine
- troglitazone
- tropicamide
- tropisetron: common
- trospium chloride: 1.86%
- trovafloxacin
- ulipristal: 6%
- ustekinumab: common, 3%
- v 1784: postmarketing, common, 3% - 8%
- valdecoxib
- valganciclovir: 2.44% - 20%
- valproate: common, 4% - 19%
- valsartan: uncommon, 1.9% - 3%
- vandetanib: 0.4% - 24%
- varenicline: 4% - 7%
- vemurafenib: postmarketing, 2% - 54%
- venlafaxine: postmarketing, common
- verapamil: 0.6% - 4.5%
- vernakalant
- vigabatrin: very common, 9% - 40%
- vilazodone: 4%
- vildagliptin: uncommon
- vincristine: 12% - 41%
- vinflunine
- vinorelbine: 0% - 49%
- vismodegib: 0.7% - 44.9%
- vorinostat
- warfarin
- zafirlukast
- zalcitabine
- zanamivir: 5% - 8%
- ziconotide
- zidovudine
- zidovudine/lamivudine
- ziprasidone: 1.6%
- zoledronic acid: postmarketing, common, very common, 2.1% - 17.6%
- zolpidem: postmarketing, infrequent, common, 1% - 3%
- zonisamide: 7% - 8%
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|
